Comparison window: 19 Dec 2013 → 8 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared
Report produced on 10 September 2026 · data as of the dates shown per section Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat Public methodology: rebalix.com/en/methodology
Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.
RebalixLU0592216393 vs LU0994505336 · report of 10 September 2026
The funds at a glance
From official issuer documents and the ESMA register
From 19 Dec 2013 to 8 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
In today’s purchasing power (net of Italy inflation)
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.
How far they fell — drawdown from peak (nominal)
In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
Filled area: LU0592216393; thin lines: the other funds.
The worst episode, fund by fund
Fund
Max drawdown
Trough
Recovery time
Underwater
LU0592216393
−39.4%
16 Mar 2020
1,037 days
1,063 days · back to break-even on 17 Jan 2023
LU0994505336
−44.7%
16 Mar 2020
1,464 days
3,263 days · back to break-even on 19 Mar 2024
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.
Drawdown net of Italy inflation
Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · LU0592216393 vs LU0994505336section 2 of 4
RebalixLU0592216393 vs LU0994505336 · report of 10 September 2026
42 common holdings · ticker match on full official portfolios
How the shared part is computed: for each security held by both funds, only the SMALLER of the two weights counts — a stock at 5% in one fund and 1% in the other overlaps by 1%, not 5%. Summed over all 42 common holdings this gives 100.0%: buying both funds, roughly this share of your money buys the same stocks twice. Matching is by company (one issuer does not publish security identifiers): identical holdings written differently may be missed, so the real overlap can be higher than shown.
Rebalix · LU0592216393 vs LU0994505336section 3 of 4
RebalixLU0592216393 vs LU0994505336 · report of 10 September 2026
Full comparison table
"—" = not published by the source, never estimated
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~266 euro LU0592216393 · ~266 euro LU0994505336. Broker costs not included.
Disclaimer
This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.
Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.
Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.
Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.
Rebalix · LU0592216393 vs LU0994505336section 4 of 4